ProBioGen Expansion Manufacturing

ProBioGen expands protein and viral vector manufacturing

German CDMO ProBioGen has announced significant expansion of its biomanufacturing capabilities through commissioning of an additional 1000L GMP production line for protein therapeutics and completion of a new viral vector manufacturing unit at its Berlin facilities.

BioRad Nuvia

Bio-Rad launches mixed-mode chromatography resin for therapeutic protein purification

Bio-Rad Laboratories has introduced a new mixed-mode chromatography resin designed for biomolecule purification across multiple scales. The Nuvia wPrime 2A Media combines weak anion exchange with hydrophobic interaction chromatography, offering potential advantages for both research and industrial-scale therapeutic protein production  

touchlight

Touchlight secures world-first GMP certification for synthetic DNA manufacturing

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Touchlight’s Hampton facility a Manufacturer’s Authorisation for Investigational Medicinal Products (MIA, IMP) licence, marking a significant advancement in synthetic DNA production. This certification enables the manufacture of Investigational Active Pharmaceutical Ingredients (API) and critical starting materials for Advanced Therapy Medicinal Products (ATMP).

terumo BCT

Terumo and FUJIFILM partner to streamline T cell expansion protocols

Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific have announced a strategic partnership to optimise T cell expansion protocols, combining Terumo BCT’s Quantum Flex Cell Expansion System with FUJIFILM’s PRIME-XV T Cell Expansion Media. This collaboration addresses significant manufacturing challenges faced by cell therapy developers, particularly those in early-stage development.

Cube biotech protein

Cube Biotech expands membrane protein capabilities through IBA Lifesciences acquisition

Monheim-based Cube Biotech has acquired IBA Lifesciences in a strategic transaction that combines two significant players in protein research and production technologies. The acquisition, announced on 13 January 2025, creates an entity with enhanced capabilities in membrane protein production, purification, and stabilisation technologies.

CN Bio OOC

CN Bio expands organ-on-chip technology distribution to Japanese market

Cambridge-based organ-on-chip (OOC) technology developer CN Bio has established a strategic partnership with Japanese distributor Primetech Corporation to expand access to its microphysiological systems throughout Japan. The collaboration arrives as the Japanese OOC market demonstrates significant growth potential, with projections indicating a market value of £22.1M by 2030, representing a compound annual growth rate of […]

Ruizhi Wang, CEO of Abselion

Analytical instrument developer Abselion raises £6.6m in Series A funding

Cambridge-based Abselion has secured £6.6 million in Series A financing to commercialise its Amperia protein analyser system, which enables rapid at-line quantification of antibodies, AAVs and other proteins from crude samples. The funding round was led by M Ventures, with participation from new and existing investors.

MLME 3

Medlab Middle East 3 – 6 February 2025

 To highlight women’s health with a new Women’s Health Leadership Forum The Women’s Health Leadership Forum at Medlab Middle East will be centred on ‘Advancing Women’s Health Through Laboratory Diagnostics’ The new forum will underscore the importance of early detection and prevention for breast cancer, cervical cancer, PCOS, and reproductive health disorders The forum will […]

Asynt12 24 imageB

Asynt’s parallel temperature-controlled overhead stirring system expands capabilities

A new temperature-controlled version of the DrySyn Vortex Parallel Overhead Stirring System has been introduced by Asynt, offering lab scientists enhanced control for multiple parallel reactions. The system enables active heating or cooling whilst maintaining efficient overhead stirring for viscous or heterogeneous reaction mixtures.  

TestaAnalytical12 24 imageA

TESTA Analytical’s real-time monitoring system offers continuous HPLC performance tracking

Scientists working with high-performance liquid chromatography (HPLC) systems can now benefit from automated, non-invasive performance monitoring through the FlowChrom system from TESTA Analytical. The technology provides continuous digital recording of HPLC operations, particularly focusing on solvent delivery system performance.